Lung Cancer

5 Questions | Total Attempts: 129

SettingsSettingsSettings
Please wait...
Lung Cancer Quizzes & Trivia

Click on the link below and read the article prior to completing the quiz. https://rms1. Newinnov. Com/Administration/GetFile. Aspx? File=3017A52AA077 42C108D91CF1BB8FA16F


Questions and Answers
  • 1. 
    A 56-year-old man is worried about his risk of developing lung cancer. He has no medical problems, but he does report having smoked one pack of cigarettes a day for 4 years while in college. He stopped smoking more than 30 years ago.   Of the following which is the most accurate statement regarding this patient's risk of developing lung cancer?
    • A. 

      It is equal to someone who has never smoked

    • B. 

      In any age group, the risk of developing lung cancer declines after stopping smoking

    • C. 

      The annual lung cancer mortality of smokers is 10 times that of nonsmokers

    • D. 

      His risk of developing lung cancer is only slightly greater than that of a nonsmoker

  • 2. 
    A 62-year-old woman presents to your clinic for a regularly scheduled examination. She has no new complaints, but she is concerned about her risk of developing lung cancer. She has smoked one pack of cigarettes a day since she was 18 years old. She asks whether she should be given any tests to screen for lung cancer.   For this patient, which of the following statements is true?
    • A. 

      Chest x-rays are a cost-effective and accurate way to screen for lung cancer

    • B. 

      Spiral computed tomography scanning is currently recommended for screening in asymptomatic patients

    • C. 

      Benign nodules are rarely seen on spiral CT, making it ideal for cancer screening

    • D. 

      At present, there are no recommended radiographic studies to screen for lung cancer

  • 3. 
    A 74-year-old man presents to your clinic with newly diagnosed nonsmall cell lung cancer (NSCLC). His concern at this visit relates to fingernail changes, which you diagnose as clubbing. He then asks whether this is a common finding in patients with lung cancer.   For this patient, which of the following statements regarding paraneoplastic syndromes is most accurate?
    • A. 

      Clubbing is the most common paraneoplastic syndrome associated with lung cancer

    • B. 

      Aberrant hormone production is more common in NSCLC than in small cell lung cancer (SCLC)

    • C. 

      Hypertrophic osteoarthropathy is the cause of clubbing in most patients with lung cancer

    • D. 

      Hypercalcemia is more common in SCLC than in NSCLC

  • 4. 
    A 64-year-old woman returns to your clinic for continued evaluation of a chronic cough, which she has been experiencing for the past 2 months. A chest x-ray obtained yesterday shows a spiculated right middle lobe mass with mediastinal lymphadenopathy. In addition, today the patient reports right leg pain of new onset. You are concerned about metastatic disease.   For this patient, which of the following approaches to diagnostic imaging would be most appropriate for the evaluation of possible metastatic disease?
    • A. 

      CT scan of the chest

    • B. 

      CT scan of the chest, head, and adrenal glands

    • C. 

      CT scan of the chest, head, and adrenal glands, and a bone scan

    • D. 

      CT scan of the chest and head, and a bone scan

  • 5. 
    A 53-year-old man presents to your clinic for evaluation of recently diagnosed NSCLC. Imaging studies showed a 3 cm tumor invading the chest wall, but there was no evidence of lymph node involvement or metastasis (T3N0M0). On the basis of this information, you inform the patient that his cancer is of stage IIb.   For this patient, which of the following statements is most accurate regarding the treatment of NSCLC?
    • A. 

      Stage II disease is treated with surgical resection

    • B. 

      Surgical intervention is recommended for stage IV disease

    • C. 

      There is no role for surgery in any stage III disease

    • D. 

      Adjuvant chemotherapy does not improve mortality for patients with stage I or stage II disease